Launched in January 2017, Nature Biomedical Engineering publishes original research, reviews and commentary of high significance to the biomedical engineering community, including bench scientists interested in devising materials, methods, technologies or therapies to understand or combat disease; engineers designing or optimizing medical devices and procedures; and clinicians leveraging research outputs in biomedical engineering to assess patient health or deliver therapy across a variety of clinical settings and healthcare contexts.

Publisher
NPG
History
2017-
Website
http://www.nature.com/natbiomedeng/

Some content from Wikipedia, licensed under CC BY-SA

Nanoparticles amplify potential cancer vaccine power

Johns Hopkins researchers have identified minuscule particles that supercharge therapeutic cancer vaccines, which train the immune system to attack tumors. These new lipid nanoparticles—tiny structures made of fat—not ...

New platform solves key problems in targeted drug delivery

In recent years, cell and gene therapies have shown significant promise for treating cancer, cystic fibrosis, diabetes, heart disease, HIV/AIDS and other difficult-to-treat diseases. But the lack of effective ways to deliver ...

Nanoplasmonic imaging reveals real-time protein secretion

EPFL researchers have used a nanoplasmonics approach to observe the real-time production of cell secretions, including proteins and antibodies; an advancement that could aid in the development of cancer treatments, vaccines, ...

Transforming the way cancer vaccines are designed and made

A new way to significantly increase the potency of almost any vaccine has been developed by researchers from the International Institute for Nanotechnology (IIN) at Northwestern University. The scientists used chemistry and ...

page 1 from 8